ABBV: MAVIRET Approved
AbbVie's MAVIRET is approved by the European Commission for acute HCV infection, becoming the only EU-approved treatment for both acute and chronic Hepatitis C Virus infection
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.